Find More Contacts for Principia Biopharma
Protected Content
Director Human Resources
1 email found
View contacts for Principia Biopharma to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@principiabio.com
  • Phone Number (650) 416-7700

Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible

covalent platform.

Lists Featuring This Company

Acquired West Coast Companies (Top 10K)
9,941 Number of Organizations â€˘ $373.3B Total Funding Amount â€˘ 35,856 Number of Investors
Acquired Oncology Companies
200 Number of Organizations â€˘ $8.5B Total Funding Amount â€˘ 449 Number of Investors
Closed United States Biotechnology Companies
2,257 Number of Organizations â€˘ $65.8B Total Funding Amount â€˘ 4,736 Number of Investors
Closed San Francisco Bay Area Companies (Top 10K)
9,996 Number of Organizations â€˘ $106.5B Total Funding Amount â€˘ 22,112 Number of Investors
Principia Biopharma was acquired by Sanofi for $3.7B on Aug 17, 2020.

Frequently Asked Questions

Where is Principia Biopharma's headquarters? Principia Biopharma is located in South San Francisco, California, United States.Who invested in Principia Biopharma? Principia Biopharma has 8 investors including Mission BioCapital and SR One.How much funding has Principia Biopharma raised to date? Principia Biopharma has raised .When was the last funding round for Principia Biopharma? Principia Biopharma closed its last funding round on Oct 16, 2019 from a Post-IPO Equity round.Who are Principia Biopharma's competitors? Alternatives and possible competitors to Principia Biopharma may include CytokineticsArcellx, and NGM Biopharmaceuticals.